Journal of Applied Physiology Millar Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 91: 789-796, 2001;
8750-7587/01 $5.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sangha, D. S.
Right arrow Articles by Purdy, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sangha, D. S.
Right arrow Articles by Purdy, R. E.
Vol. 91, Issue 2, 789-796, August 2001

Simulated microgravity upregulates an endothelial vasoconstrictor prostaglandin

Deepali S. Sangha, Sukgu Han, and Ralph E. Purdy

Department of Pharmacology, College of Medicine, University of California, Irvine, California 92697-4625

Endothelial nitric oxide contributes to the vascular hyporesponsiveness to norepinephrine (NE) observed in carotid arteries from rats exposed to simulated microgravity. The goal of the present study was to determine whether a cyclooxygenase product of arachidonic acid also influences vascular responsiveness in this setting. Microgravity was simulated in rats by hindlimb unweighting (HU). After 20 days of HU, carotid arteries were isolated from control and HU-treated rats, and vascular rings were mounted in tissue baths for the measurement of isometric contraction. Two cyclooxygenase inhibitors, indomethacin and ibuprofen, and the selective thromboxane A2 prostanoid-receptor antagonist, SQ-29548, had no effect on the contraction to NE in control vessels but markedly reduced contraction to NE in HU vessels. When the endothelium was removed, indomethacin no longer had any effect on the NE-induced contraction in HU vessels. In endothelium-intact vessels in the presence of indomethacin, the addition of the nitric oxide synthase inhibitor, NG-L-nitro-arginine methyl ester, to the medium bathing HU vessels increased the contraction to NE to the level of that of the control vessels. These results indicate that HU treatment induced two endothelial changes in carotid artery that opposed each other. Nitric oxide activity was increased and was responsible for the vascular hyporesponsiveness to NE. The activity of a vasoconstrictor prostaglandin was also increased, and attenuated the vasodilating effect of nitric oxide.

cyclooxygenase; endothelium; hindlimb unweighting; nitric oxide; vasoconstriction


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. C. Barbato, Q.-Q. Huang, M. M. Hossain, M. Bond, and J.-P. Jin
Proteolytic N-terminal Truncation of Cardiac Troponin I Enhances Ventricular Diastolic Function
J. Biol. Chem., February 25, 2005; 280(8): 6602 - 6609.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
A. Graebe, E. L. Schuck, P. Lensing, L. Putcha, and H. Derendorf
Physiological, Pharmacokinetic, and Pharmacodynamic Changes in Space
J. Clin. Pharmacol., August 1, 2004; 44(8): 837 - 853.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online